Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cirrhosis, Familial, with Pulmonary Hypertension × donafenib × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Cholangiocarcinoma 2 Cirrhosis, Familial, with Pulmonary Hypertension 1 Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 3 Oxaliplatin 2 Leucovorin 2 lenvatinib 1 gemcitabine-oxaliplatin regimen 1 durvalumab 1 donafenib 1 Irinotecan 1 Folfox protocol 1 Floxuridine 1 Drug Therapy 1 Dexamethasone 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07353827 2026-01-20

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Sun Yat-sen University

Phase 2 Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡